11.07.2015 Views

Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

4 I. FOUNDATIONS OF ADDICTIONWhile the individual patient, rather than his or her disease, is the appropriatefocus <strong>of</strong> treatment for substance abuse, an understanding <strong>of</strong> the neurobiology<strong>of</strong> dependence and addiction can clarify the rationales for treatment methodsand goals. Patients who are inform<strong>ed</strong> about the brain origins <strong>of</strong> addictionalso can benefit from understanding that their addiction has a biological basisand does not mean that they are “bad” people.Brain abnormalities resulting from chronic use <strong>of</strong> nicotine, stimulants,opioids, alcohol, hallucinogens, inhalants, cannabis, and many other abus<strong>ed</strong>substances are underlying causes <strong>of</strong> dependence (the ne<strong>ed</strong> to keep taking drugsto avoid a withdrawal syndrome) and addiction (intense drug craving and compulsiveuse). Most <strong>of</strong> the abnormalities associat<strong>ed</strong> with dependence resolveafter detoxification, within days or weeks after the substance use stops. Theabnormalities that produce addiction, however, are more wide-ranging, complex,and long-lasting. They may involve an interaction <strong>of</strong> environmentaleffects—for example, stress, the social context <strong>of</strong> initial opiate use, and psychologicalconditioning—and a genetic pr<strong>ed</strong>isposition in the form <strong>of</strong> brain pathwaysthat were abnormal even before the first dose <strong>of</strong> opioid was taken. Suchabnormalities can produce craving that leads to relapse months or years afterthe individual is no longer opioid-dependent.In this chapter we describe how drugs affect brain processes to produce drugliking, tolerance, dependence, and addiction. Although these processes arehighly complex, like everything that happens in the brain, we try to explain themin terms that can be understood by patients. We also discuss the treatment implications<strong>of</strong> these concepts. Pharmacological therapy directly <strong>of</strong>fsets or reversessome <strong>of</strong> the brain changes associat<strong>ed</strong> with dependence and addiction, greatlyenhancing the effectiveness <strong>of</strong> behavioral therapies. Although researchers do notyet have a comprehensive understanding about how these m<strong>ed</strong>ications work, it isclear that they <strong>of</strong>ten renormalize brain abnormalities that have been induc<strong>ed</strong> bychronic, high-dose abuse <strong>of</strong> various substances.ORIGINS OF DRUG LIKINGMany factors, both individual and environmental, influence whether a particularperson who experiments with drugs will continue taking them long enoughto become dependent or addict<strong>ed</strong>. For individuals who do continue, the drug’sability to provide intense feelings <strong>of</strong> pleasure is a critical reason.When abus<strong>ed</strong> drugs travel through the bloodstream to the brain, theyattach to specializ<strong>ed</strong> proteins on the surface <strong>of</strong> neurons that may be receptors,transporters, or even structural elements <strong>of</strong> the neurons. For example, opiatessuch as heroin bind to mu opioid receptors, which are on the surfaces <strong>of</strong> opiatesensitiveneurons, and have their effects by inhibiting the cyclic adenosinemonophosphate (cyclic AMP) second messenger system. Inhibition occurs

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!